Abstract
The complex nature of Alzheimer's disease calls for multidirectional treatment. Consequently, the search for multi-target-directed ligands may lead to potential drug candidates. The aim of the present study is to seek multifunctional compounds with expected activity against disease-modifying and symptomatic targets. A series of 15 drug-like various substituted derivatives of 2-(benzylamino-2-hydroxyalkyl)isoindoline-1,3-diones was designed by modification of cholinesterase inhibitors toward beta-secretase inhibition. All target compounds have been synthesized and tested against eel acetylcholinesterase (eeAChE), equine serum butyrylcholinesterase (eqBuChE), human %-secretase (hBACE-1), and beta-amyloid (A beta-aggregation). The most promising compound, 12 (2-(5-(benzylamino)-4-hydroxypentyl)isoindoline-1,3-dione), displayed inhibitory potency against eeAChE (IC50 = 3.33 microM), hBACE-1 (43.7% at 50 microM), and A beta-aggregation (24.9% at 10 microM). Molecular modeling studies have revealed possible interaction of compound 12 with the active sites of both enzymes acetylcholinesterase and beta-secretase. In conclusion: modifications of acetylcholinesterase inhibitors led to the discovery of a multipotent anti-Alzheimer's agent, with moderate and balanced potency, capable of inhibiting acetylcholinesterase, a symptomatic target, and disease-modifying targets: beta-secretase and A beta-aggregation.
Keywords
isoindoline-1,3-dione derivatives;cholinesterase inhibitors;BACE-1 inhibitors;Abeta-aggregation;molecular modeling;multiple anti-Alzheimer's ligands;
Data
Language: |
English |
Year of publishing: |
2018 |
Typology: |
1.01 - Original Scientific Article |
Organization: |
UL FFA - Faculty of Pharmacy |
UDC: |
616.894:615 |
COBISS: |
4473713
|
ISSN: |
1420-3049 |
Views: |
222 |
Downloads: |
173 |
Average score: |
0 (0 votes) |
Metadata: |
|
Other data
Secondary language: |
Slovenian |
Secondary keywords: |
Alzheimerjeva bolezen; |
Type (COBISS): |
Article |
Pages: |
str. 1-15 |
Volume: |
ǂVol. ǂ23 |
Issue: |
ǂiss. ǂ2 |
Chronology: |
2018 |
DOI: |
10.3390/molecules23020347 |
ID: |
13641446 |